Belite Bio, Inc Belite Bio, Inc

Belite Bio, Inc

BLTE

Rang in Aktien #3051
Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the... Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical trials, LBS-008 is engineered to modulate vitamin A delivery to the eye, thus preventing the accumulation of detrimental vitamin A metabolites in ocular tissues. Furthermore, Belite Bio is advancing LBS-009, an oral anti-retinol binding protein 4 therapy, through preclinical development. This therapy targets various liver ailments, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Founded in 2016, Belite Bio, Inc. is headquartered in San Diego, California, and operates as a subsidiary of Lin Bioscience International Ltd.
Aktienkurs
$148.24
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$5.97B
Veränderung (1 Tag)
3.82%
Veränderung (1 Jahr)
64.04%
Land
US
Handel Belite Bio, Inc (BLTE)

Kategorie

Healthcare
Aktien-Split-Historie für Belite Bio, Inc (BLTE)
Die Aktie Belite Bio, Inc (Symbol: BLTE) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 20, 2026 statt.
Eine BLTE-Aktie, die vor dem Oct 20, 2026 gekauft wurde, entspricht heute 0 BLTE-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL